SOLV Revenue second quarter 2026 Y/Y Growth Comment
Solventum Corporation achieved in the second quarter 2026, above Company average Revenue improvement of 2.22% year on year, to $ 2,209.00 millions.
Looking into second quarter 2026 results within Medical Equipment & Supplies industry 133 other companies have achieved higher Revenue growth. While Solventum Corporation' s Revenue increase of 2.22% ranks overall at the positon no. 2539 in the second quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Solventum's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
10.06 %
0.79 %
-4.68 %
(Jun 30 2026)
SOLV's II. Quarter Q/Q Revenue Comment
Solventum Corporation achieved in the II. Quarter 2026 above company average sequential Revenue rise of 10.06%, to $ 2,209.00 millions, from $2,007.00 millions in the first quarter. SOLV is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Solventum's Revenue growth quarter on quarter, overall rank is 819.
Solventum Corporation achieved in the II. Quarter 2026 above company average sequential Revenue rise of 10.06%, to $ 2,209.00 millions, from $2,007.00 millions in the first quarter. SOLV is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 32 other companies have achieved higher Revenue quarter on quarter growth. While Solventum's Revenue growth quarter on quarter, overall rank is 819.
Solventum's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Jun 30 2026)
12 Months Ending (Mar 31 2026)
12 Months Ending (Dec 31 2025)
12 Months Ending (Sep 30 2025)
12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending
$ 8,310.00
$ 8,262.00
$ 8,325.00
$ 8,402.00
$ 8,388.00
Y / Y Revenue Growth (TTM)
-0.93 %
-0.55 %
0.86 %
2.28 %
2.21 %
Year on Year Revenue Growth Overall
Ranking
# 2397
# 2307
# 2090
# 0
# 0
Seqeuential Revenue Change (TTM)
0.58 %
-0.76 %
-0.92 %
0.17 %
0.96 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2539
# 2367
# 2112
# 1951
# 0
Cumulative Revenue growth Comment
Solventum's cumulative 12 months Revenue continue to decrease, but on the faster rate at -0.93% year on year, at Jun 30 2026 compare to the -0.55% decrease at Mar 31 2026. If the Solventum's fiscal year would end at Jun 30 2026, annual Revenue would be $8,310 millions.
In the Healthcare sector 344 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2307 to 2397.
Solventum's cumulative 12 months Revenue continue to decrease, but on the faster rate at -0.93% year on year, at Jun 30 2026 compare to the -0.55% decrease at Mar 31 2026. If the Solventum's fiscal year would end at Jun 30 2026, annual Revenue would be $8,310 millions.
In the Healthcare sector 344 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2307 to 2397.
About Solventum Revenue Growth Rates (SOLV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
3.76%